Aller au contenu principal
Profil bibliographique

Rupendra N. Shrestha

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

141Publications signalées
6316Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Retirement, Disability, and EmploymentHealth Systems, Economic Evaluations, Quality of Lifedemographic modeling and climate adaptationHealth disparities and outcomesGlobal Health Care Issues

Les publications récentes

2026 article OpenAlex

The Australian PreGen Study: Results From Prospective Prenatal Exome Sequencing in 275 Pregnancies

Conor Rowntree, Gemma Fernihough, Sarah S. Long, Mohammad Al-Shinnag et autres

ABSTRACT Objective Prenatal exome sequencing (pES) is increasingly to standard care for diagnosing the etiology of fetal structural anomalies (FSA). We evaluated trio pES outcomes in the national multicentre, prospectively recruited Australian Government‐funded cohort, including diagnostic yield, frequency of variants of uncertain …

au, sa (code pays fourni par la source)

0 citations Prenatal Diagnosis
Accès ouvert 2026 article OpenAlex

The quality-of-life impacts and economic burden of X-linked retinitis pigmentosa caused by variants in RPGR

DEBORAH J. SCHOFIELD, Joshua Kraindler, Rupendra N. Shrestha, Owen Tan et autres

OBJECTIVES: To estimate the health and societal costs and health-related quality of life (HRQoL) impacts of X-linked retinitis pigmentosa (XLRP) caused by RPGR. METHODS: Primary data were obtained from a clinical cohort of 9 patients with X-linked retinitis pigmentosa (XLRP) and 4 …

au (code pays fourni par la source)

0 citations Eye
Accès ouvert 2026 article OpenAlex

Motor Neuron Disease Mortality Trends in Australia From 1986 to 2023: A Population‐Based Study

Carol M. Y. Lee, Rupendra N. Shrestha, Julian Gold, Mark Stevenson et autres

OBJECTIVES: To analyse longitudinal change in motor neuron disease (MND) mortality in Australia from 1986 to 2023. DESIGN: Australian population-based study of MND mortality. SETTING: All MND mortality and Australian population data from 1 January 1986 to 31 December 2023 were obtained …

au (code pays fourni par la source)

1 citation The Medical Journal of Australia
Accès ouvert 2025 article OpenAlex

Health-related quality of life in patients with mitochondrial disease and their carers

DEBORAH J. SCHOFIELD, Joshua Kraindler, Katherine K. Lim, Owen Tan et autres

BACKGROUND: Mitochondrial diseases are a group of rare, chronic disorders with a significant disease burden; however, there is limited knowledge about their effects on the health-related quality of life (HRQoL) of patients and their carers. This study estimates HRQoL among adult patients …

au (code pays fourni par la source)

0 citations Journal of Medical Genetics
Accès ouvert 2025 article OpenAlex

Cost-effectiveness analysis of active day patient treatment, an interdisciplinary pain self-management program

Anonnya Rizwana Chowdhury, DEBORAH J. SCHOFIELD, Rupendra N. Shrestha, Michael K. Nicholas

Introduction: Active day patient treatment (ADAPT) is an interdisciplinary, multimodal pain management program for patients with disabling chronic pain at the Pain Management & Research Centre (PMRC), Royal North Shore Hospital in Sydney, Australia. Objective: The aim of this study was to …

au (code pays fourni par la source)

0 citations PAIN Reports
Accès ouvert 2025 article OpenAlex

The Burden of Mitochondrial Disease: Healthcare and Societal Costs

DEBORAH J. SCHOFIELD, Katherine K. Lim, Owen Tan, Rupendra N. Shrestha et autres

OBJECTIVES: To estimate the burden of mitochondrial disease by measurement of healthcare, societal, and lifetime costs of mitochondrial disease. METHODS: We recruited patients aged 18 years or over with a clinical confirmation of mitochondrial disease and their carer from a mitochondrial disease …

au (code pays fourni par la source)

4 citations Value in Health
Accès ouvert 2025 article OpenAlex

Cost-effectiveness of population-based expanded reproductive carrier screening for genetic diseases in Australia: a microsimulation analysis

DEBORAH J. SCHOFIELD, Evelyn Lee, Jayamala Parmar, Adriana C. Castelo Taboada et autres

Using the Australian Census survey 2021 as base population, a microsimulation model, PreconMOD was developed to evaluate the cost-effectiveness of population-based expanded reproductive carrier screening (RCS) for 569 recessive conditions from the health service and societal perspectives. The model simulated the effect …

au (code pays fourni par la source)

3 citations European Journal of Human Genetics
Accès ouvert 2024 article OpenAlex

Adolescent risk behaviours are associated with educational attainment in early adulthood: results from the Raine Study cohort

Petra L. Graham, DEBORAH J. SCHOFIELD, Robert J. Tait, Sarita Bista et autres

BACKGROUND: Higher educational attainment is important for economic wellbeing and associated with better health and longevity. Previous research focused on intelligence, socioeconomic status and mental health or individual risk behaviours as predictors of educational attainment, but the role of multiple domains of …

au (code pays fourni par la source)

2 citations BMC Public Health
Accès ouvert 2024 article OpenAlex

The economic costs of precision medicine for clinical translational research among children with high-risk cancer

Christopher EL Owens, Owen Tan, Joice Kuroiwa‐Trzmielina, Rupendra N. Shrestha et autres

Embedding precision medicine in paediatric oncology shows promise to have a positive impact on how children with cancer will be treated in the future. While there are a number of studies of precision medicine in childhood cancer, there is limited evidence available …

au (code pays fourni par la source)

12 citations npj Precision Oncology
Accès ouvert 2024 article OpenAlex

Cascade testing in mitochondrial diseases: a cross-sectional retrospective study

Sameen Haque, Karen Crawley, DEBORAH J. SCHOFIELD, Rupendra N. Shrestha et autres

BACKGROUND: Cascade testing can offer improved surveillance and timely introduction of clinical management for the at-risk biological relatives. Data on cascade testing and costs in mitochondrial diseases are lacking. To address this gap, we performed a cross-sectional retrospective study to provide a …

au (code pays fourni par la source)

3 citations BMC Neurology
Accès ouvert 2024 article OpenAlex

Social provisions in patients with mitochondrial diseases

Sameen Haque, Karen Crawley, DEBORAH J. SCHOFIELD, Rupendra N. Shrestha et autres

Background: Mitochondrial diseases often follow a chronic, multimorbid disease course in adults. Like other chronic conditions, mitochondrial diseases present a challenge to public and community health models and patients are potentially at higher risk of social isolation and loneliness. However, there is …

au (code pays fourni par la source)

1 citation BMJ Neurology Open
Accès ouvert 2024 article OpenAlex

Clinical drivers of hospitalisation in patients with mitochondrial diseases

Sameen Haque, Karen Crawley, Ryan L. Davis, DEBORAH J. SCHOFIELD et autres

Background Mitochondrial diseases in adults are generally chronic conditions with a wide spectrum of severity contributing to disease burden and healthcare resource utilisation. Data on healthcare resource utilisation in mitochondrial diseases are limited. Objectives We performed a retrospective longitudinal study to investigate …

au (code pays fourni par la source)

1 citation BMJ Neurology Open

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.